A more relevant dissolution method for evaluation of floating drug delivery system

Dissolution Technologies

Volumn 11, Issue 4, 2004, Pages 22-25

  Gohel, Mukesh C ^a   Mehta, Pavak R ^a   Dave, Rikita K ^a   Bariya, Nehal H ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CARBON DIOXIDE;

ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ANALYTICAL PARAMETERS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISSOLUTION METHOD; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EFFERVESCENT TABLET; EQUIPMENT DESIGN; FLOATING DRUG DELIVERY SYSTEM; STOMACH ACID SECRETION; STOMACH EMPTYING; STOMACH VOLUME;

EID: 84962110847     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT110404P22     Document Type: Article

References (15)

1. Streubel, A., Siepmann, J., Bodmeier, R., " Floating microparticles based on low density foam powder." Int. J. Pharm., 241, 279-292, 2002.
2. Moes, A. J., " Gastroretentive dosage forms." Crit. Rev. Ther. Drug Carrier Syst. 10, 143-145, 1993.
3. Deshpande, A. A., Rhodes, C. T, Shah, N. H., Malick, A. W., " Controlled release drug delivery systems for prolonged gastric residence: an overview." Drug Dev. Ind. Pharm. 22, 531-539, 1996.
4. Rouge, N., Buri, P., Doelker, E., " Drug absorption sites in the gastrointestinal tract and dosage forms for site specific delivery." Int. J. Pharm. 136, 117-139, 1996.
5. Hwang, S. J., Park, H., Park, K., " Gastric retentive drug delivery systems." Crit. Rev. Ther. Drug Carrier Syst. 15, 243-284, 1998.
6. Singh, B. N., Kim, K. H., " Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention." J. Control. Release. 63, 235-259, 2000.
7. Desai, S., Bolton, S., " A floating controlled release drug delivery system. In vitro and in vivo evaluation." Pharm. Res. 10, 1321-1325, 1993.
8. Burns, S. J., Attwood, D., Barnwell, S. G., " Assessment of a dissolution vessel designed for use with floating and erodible dosage forms." Int. J. Pharm. 160, 213-218, 1998.
9. Durig, T., Fassihi, R., " Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test." J. Control. Release. 67, 37-44, 2000.
10. Splvey, R. J., and Goodhart, F. W., " In vitro acid reactivity of three commercial antacid tablets." Am. J. Hosp Pharm, 36(May), 660-663, 1979.
11. Rohrs, B. R., " Dissolution method development for poorly soluble compounds." Dissolution Technologies, 8 (3), 6-12, 2001.
12. Technical Brochure of Sotax, web site: www. Sotax. com.
13. Moore, J. W., and Flanner, H. H., " Mathematical comparison of dissolution profile." P. T., 20 (6), 64-74, 1996.
14. US Food and Drug Administration, Rockville, MD USA (1997) Guidance for industry, Dissolution testing of immediate release solid oral dosage form.
15. Shah, V. P., Tsong, Y., Sathe, P., and Lin, J., " In vitro dissolution profile comparison-statistics and analysis of the similarity factor f2." Pharm. Res., 15(6), 889-896, 1998.